Search Results - K. Vervisch
- Showing 1 - 4 results of 4
-
1
O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR by S. Rutsaert, W. Trypsteen, C. Van Hecke, M.A. De Scheerder, M. Kiselinova, K. Vervisch, W. De Spiegelaere, L. Vandekerckhove
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Impact of a decade of sustained antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs by S. Kinloch, E. Malatinkova, W. De Spiegelaere, P. Bonczkowsk, M. Kiselinova, K. Vervisch, W. Trypsteen, M. Johnson, D. de Looze, L. Vandekerckhove
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients by C. Van Hecke, E. Malatinkova, W. De Spiegelaere, M. Sips, K. Vervisch, C. Verhofstede, M. Johnson, S. Kinloch-de Loës, W. Trypsteen, L. Vandekerckhove
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? by P. Pannus, P. Adams, E. Willems, L. Heyndrickx, M. Van Frankenhuijsen, E. Florence, M. Kiselinova, S. Rutsaert, K. Vervisch, W. Despiegelaere, C. Devaux, L. Vandekerckhove, G. Vanham
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book